MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1007/s00066-026-02516-1

Медицинская библиотека · Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] · 2026

Comparative analysis of different modalities of radiotherapy in vestibular schwannoma: tumor control, symptom evolution, and toxicity profiles.

Lishewski Phillipp, Fischer Maike, Tas Kerem Tuna, Sheikhzadeh Fatima Frosan, Smalec Edgar, Agolli Linda, Nimsky Christopher, Kemmling André, Habermehl Daniel, Zink Klemens, Gawish Ahmed, Adeberg Sebastian

СтатьяСравнительное исследованиеПеревод в очереди

Аннотация

BACKGROUND

Stereotactic radiotherapy (SRT) is a standard treatment for vestibular schwannoma (VS). Long-term comparative data on single-fraction radiosurgery (SRS) versus normofractionated SRT (NFSRT) are limited.

METHODS

We retrospectively analyzed 175 VS patients treated between 1998 and 2023 (SRS n = 69; NFSRT n = 106; median age 61 years; median follow-up 46 months). Tumor control was evaluated with Kaplan-Meier and Cox regression. Group differences were tested with Mann-Whitney U and chi-square/Fisher's exact tests. Symptom changes were assessed with McNemar tests, and binary logistic regression identified predictors of acute and late toxicity.

RESULTS

Overall, in-field PFS was 94.3% and out-field was PFS was 99.4%. All 10 recurrences (median 58.5 months) occurred in NFSRT patients treated with 55.8-56 Gy. Higher total dose predicted recurrence (HR = 2.97; p = 0.003). At baseline, 97.1% reported symptoms (hearing loss 86.9%, vertigo 48.0%, tinnitus 42.3%). After therapy, symptoms remained stable, except the incidence of headache, which increased from 14.3% to 22.3% (p = 0.02). Early toxicities were more common after NFSRT, including headache (OR = 4.05; p = 0.01), fatigue (OR = 5.12; p = 0.01), and alopecia (OR = 19.9; p = 0.04), but had resolved by late follow-up. Age and prior surgery predicted vertigo patterns over time. Radionecrosis was rare (0.6%).

CONCLUSION

Both SRS and NFSRT achieve excellent long-term tumor control with low severe toxicity. For NFSRT, normofractionated doses above 55 Gy did not improve efficacy and may increase the recurrence risk, supporting moderate-dose regimens (50-54 Gy). Symptom stabilization confirms the safety of SRT, though headache and vertigo remain relevant long-term issues. Careful dose selection, patient counseling, and rehabilitation are essential to optimize outcomes.

Для цитирования: Lishewski Phillipp, Fischer Maike, Tas Kerem Tuna, Sheikhzadeh Fatima Frosan, Smalec Edgar, Agolli Linda, Nimsky Christopher, Kemmling André, Habermehl Daniel, Zink Klemens, Gawish Ahmed, Adeberg Sebastian. Comparative analysis of different modalities of radiotherapy in vestibular schwannoma: tumor control, symptom evolution, and toxicity profiles.. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]. 2026. DOI: 10.1007/s00066-026-02516-1.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.